suivi-COVID - Evaluation of the post-COVID-19 functional status (PCFS) scale as a screening tool for sequelae in patients with COVID-19 hypoxic pulmonary disease
Head :
Eschapasse Emmanuel
Last update : 04/22/2021 | Version : 1 | ID : 73841
| General | |
| Identification | |
| Detailed name | Evaluation of the post-COVID-19 functional status (PCFS) scale as a screening tool for sequelae in patients with COVID-19 hypoxic pulmonary disease |
| Sign or acronym | suivi-COVID |
| General Aspects | |
| Medical area |
Pneumology |
| Study in connection with Covid-19 |
Yes |
| Pathology (details) | sequelae of hypoxic pulmonary disease |
| Health determinants |
Others (specify) |
| Others (details) | nothing in particular |
| Keywords | functional status scale, Pneumonia |
| Scientific investigator(s) (Contact) | |
| Name of the director | Eschapasse |
| Surname | Emmanuel |
| Address | HGRL CHU Nantes |
| ESCHAPASSE Emmanuel <Emmanuel.ESCHAPASSE@chu-nantes.fr> | |
| Organization | Nantes University Hospital CIC |
| Collaborations | |
| Participation in projects, networks and consortia |
No |
| Funding | |
| Funding status |
Private |
| Details | Pays de la Loire Respiratory Health Research Institute |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Nantes University Hospital |
| Organisation status |
Public |
| Presence of scientific or steering committees |
No |
| Additional contact | |
| Name of the contact | Lemarchand |
| Surname | Patricia |
| Address | l'institut du thorax - UMR Inserm 1087/CNRS 6291<br>IRS-UN, 8 quai Moncousu, BP 70721<br>44007 Nantes cedex 1, France |
| patricia.lemarchand@univ-nantes.fr | |
| Unit | Thorax Institute - UMR Inserm 1087/CNRS 6291 |
| Organization | Inserm |
| Main features | |
| Type of database | |
| Type of database |
Others |
| Specify | medical hospitalisation and follow-up data |
| Study databases (details) |
Longitudinal study (except cohorts) |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is is made on the basis of: |
Another treatment or procedure |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. |
The population concerned brings together patients aged 18 to 75 years, admitted to Nantes University Hospital for pulmonary disease requiring supplemental oxygen therapy (known as hypoxic pulmonary disease) attributed to SARS-CoV-2 based on a positive PCR or chest CT scan criteria, having completed the PCFS and mMRC questionnaires.
These patients will constitute the Nantes post-COVID-19 follow-up cohort. As part of their management, they will be offered routine follow-up at 3 months, either as a pulmonology appointment if standard hospitalisation was required, or in the outpatient clinic setting allowing a wider panel of tests to be performed, if admission to an intensive care unit was warranted due to the initial severity of the infection, with or without invasive ventilation. More than 700 patients tested positive for SARS-CoV-2 at Nantes University Hospital between February and June 2020. Approximately one hundred of these patients fulfil the criteria for age and severity of pulmonary disease, and are therefore eligible for this follow-up. |
| Database objective | |
| Main objective | The primary objective of this project is to propose a French translation and assess the post-COVID-19 functional status (PCFS) scale as a screening tool for respiratory sequelae in patients with COVID-19 hypoxic pulmonary disease after 3 months in the Nantes COVID-19 hypoxic pulmonary disease cohort, attending an appointment at Nantes University Hospital. The primary endpoint will be to assess the Spearman correlation between the PCFS scale and the mMRC (modified Medical Research Council) scale. |
| Inclusion criteria |
Adult patient, aged under 75 years, having been admitted to Nantes University Hospital for hypoxic pulmonary disease, defined by the need for supplemental oxygen therapy for at least 24 hours, associated with a diagnosis of SARS-CoV-2 infection confirmed by PCR or CT scan lesions consistent with infection in the event of a negative PCR, attending the 3 month follow-up visit, and having completed the PCFS and mMRC questionnaires.
|
| Population type | |
| Age |
Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Pathology | J12 - Viral pneumonia, not elsewhere classified |
| Gender |
Male Woman |
| Geography area |
Regional |
| French regions covered by the database |
Pays de la Loire |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2020 |
| Date of last collection (YYYY or MM/YYYY) | 2021 |
| Size of the database | |
| Size of the database (number of individuals) |
< 500 individuals |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Clinical data Declarative data Paraclinical data Biological data |
| Clinical data (detail) |
Direct physical measures Medical registration |
| Declarative data (detail) |
Paper self-questionnaire |
| Procedures | |
| Participant monitoring |
No |
| Followed pathology | |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Access |
